Abstract:Glioblastoma, an invariably lethal brain tumor, undergoes marked metabolic alterations during tumorigenesis and is extraordinarily difficult to treat. Detecting recurrence after treatment and understanding metabolic alterations within the tumor microenvironment are extremely challenging. An exciting and emerging imaging methodology, deuterium metabolic imaging (DMI), detects metabolic adaptations via non-radioactively labeled deuterated substrates. This study developed approaches to image lipid synthesis with deuterium oxide (D 2 O) and metabolism with D 31 -palmitate (D 31 -Pal) in glioblastoma. A fatty-acid phantom was generated for characterization of lipid DMI signal at 12 T. DMI was performed in mice orthotopically implanted with GL261 glioblastoma utilizing either orally administered D 31 -Pal or D 2 O and was correlated with pharmacokinetic metabolic measurements from mouse serum. Mice were either orally gavaged with an emulsion of D 31 -Pal prior to imaging or provided 16% D 2 O for ad libitum consumption following tumor implantation. Although D 2 O administration resulted in robust enrichment of lipid signal in GBM, D 31 -Pal uptake and metabolism were not significantly detected within intracranial tumors. Interestingly, D 31 -Pal uptake and metabolism were detected in normal tissues, indicating preferential utilization of fatty acids in non-neoplastic tissues. These findings suggest de novo lipogenesis within GBM, rather than uptake of administered long chain fatty acids, is the preferential pathway for cellular lipids. DMI can assist in interrogating GBM fatty-acid synthesis and metabolism, as well as furthering our understanding of lipid distribution within the body by providing a non-invasive scaffold for dynamic interrogation of fatty-acid distribution in an oncologic model. Developing a non-invasive method for characterization of tumor fatty-acid synthesis and metabolism may improve our understanding of tumor metabolism and could dynamically guide selection of patient-tailored metabolic therapies in the future.

Synthesis of deuterated γ-linolenic acid and application for biological studies: metabolic tuning and Raman imaging

Subcellular Tracking of Deuterated Drugs by Stimulated Raman Scattering Microscopy

Deuterium Raman imaging for lipid analysis

Synthesis of Deuterium Labelled Diclofenac with Improved Isotopic Enrichment

Synthesis and Biological Evaluation of Novel Spin Labeled 18Β-Glycyrrhetinic Acid Derivatives

Design, Synthesis and Structure-Activity Relationship Studies of Glycosylated Derivatives of Marine Natural Product Lamellarin D

Nimg-69. Interrogation Of Glioblastoma Fatty-Acid Synthesis And Metabolism With Deuterium Metabolic Imaging

Recent advances in the analysis of the site-specific isotopic fractionation of metabolites such as fatty acids using anisotropic natural-abundance 2H NMR spectroscopy: application to conjugated linolenic methyl esters

Deuterated reagents in multicomponent reactions to afford deuterium-labeled products

Advantages of deuterium modification of nitroxide spin labels for biological epr studies

In vivo deuterium magnetic resonance imaging of xenografted tumors following systemic administration of deuterated water

Synthesis and Characterization of Dual Radiolabeled Layered Double Hydroxide Nanoparticles for Use in In Vitro and In Vivo Nanotoxicology Studies

Photocatalytic and highly regioselective H/D exchange at alpha-thio C(sp3)-H bonds

Evaluation of enzymatic and magnetic properties of γ-glutamyl-[1-13C]glycine and its deuteration toward longer retention of the hyperpolarized state

In-vivo tracking of deuterium metabolism in mouse organs using LC-MS/MS

Deuterium MRI of serine metabolism in mouse models of glioblastoma

Raman optical activity study of deuterated sugars: deuterium labelling as a tool for structural analysis

Deuterated Malonamide Synthesis for Fundamental Research on Solvent Extraction Systems

Chemical Basis for Deuterium Labeling of Fat and NADPH

Deuterium Labeling of Isoaspartic and Isoglutamic Acids for Mass Spectrometry Analysis

Synthesis of A Tetra-Deuterium-Labeled Derivative of Potent and Selective Anticancer Agent Aa005